$AIM
AIM ImmunoTech Inc. Stock $aim

$aim Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032118 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$56.00K	$21.00K	$33.00K
YoY Change	12.0%	-36.36%	-8.33%
Cost Of Revenue	$0.00	$0.00	$157.0K
YoY Change	-100.0%	-100.0%	-23.04%
Gross Profit	$56.00K	$21.00K	-$124.0K
YoY Change	-144.44%	-116.94%	-26.19%
Gross Profit Margin	100.0%	100.0%	-375.76%
Selling, General & Admin	$3.505M	$5.170M	$1.799M
YoY Change	33.93%	187.38%	-13.72%
% of Gross Profit	6258.93%	24619.05%
Research & Development	$2.107M	$1.372M	$2.006M
YoY Change	-27.92%	-31.61%	82.03%
% of Gross Profit	3762.5%	6533.33%
Depreciation & Amortization	$170.0K	$28.00K	$176.0K
YoY Change	-12.37%	-84.09%	31.34%
% of Gross Profit	303.57%	133.33%
Operating Expenses	$5.612M	$1.372M	$3.805M
YoY Change	1.3%	-63.94%	19.39%
Operating Profit	-$5.556M	-$6.521M	-$3.929M
YoY Change	-1.94%	65.97%	17.11%
Interest Expense	$423.0K
YoY Change	-240.53%
% of Operating Profit
Other Income/Expense, Net	$0.00	$172.0K	$51.00K
YoY Change	-100.0%	237.25%	64.52%
Pretax Income	-$4.389M	-$6.385M	-$3.826M
YoY Change	-24.92%	66.88%	15.73%
Income Tax
% Of Pretax Income
Net Earnings	-$4.389M	-$6.385M	-$3.826M
YoY Change	-24.92%	66.88%	15.73%
Net Earnings / Revenue	-7837.5%	-30404.76%	-11593.94%
Basic Earnings Per Share		-$0.13	-$0.08
Diluted Earnings Per Share	-$0.09	-$132.8K	-$79.96K
COMMON SHARES
Basic Shares Outstanding	48.08M shares	48.05M shares
Diluted Shares Outstanding		48.08M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.19M	$36.75M	$37.85M
YoY Change	-29.17%	-2.91%	-4.52%
Cash & Equivalents	$27.05M	$29.76M	$37.35M
Short-Term Investments	$7.137M	$6.986M	$499.0K
Other Short-Term Assets	$455.0K	$4.405M	$161.0K
YoY Change	49.67%	2636.02%	76.92%
Inventory
Prepaid Expenses
Receivables	$1.676M	$0.00	$28.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$36.32M	$41.15M	$38.04M
YoY Change	-27.67%	8.18%	-4.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$195.0K	$118.0K	$6.138M
YoY Change	-95.18%	-98.08%	-9.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$15.81M
YoY Change			6.57%
Other Assets	$1.202M	$2.138M	$1.249M
YoY Change	-8.66%	71.18%	-7.28%
Total Long-Term Assets	$4.167M	$5.135M	$25.04M
YoY Change	-44.34%	-79.5%	2.61%
TOTAL ASSETS
Total Short-Term Assets	$36.32M	$41.15M	$38.04M
Total Long-Term Assets	$4.167M	$5.135M	$25.04M
Total Assets	$40.49M	$46.29M	$63.08M
YoY Change	-29.83%	-26.62%	-1.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$377.0K	$957.0K	$369.0K
YoY Change	90.4%	159.35%	80.0%
Accrued Expenses	$806.0K	$1.767M	$398.0K
YoY Change	84.02%	343.97%	9.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.361M	$2.895M	$767.0K
YoY Change	102.23%	277.44%	-3.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$659.0K	$695.0K	$266.0K
YoY Change	348.3%	161.28%	-17.65%
Total Long-Term Liabilities	$659.0K	$695.0K	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.361M	$2.895M	$767.0K
Total Long-Term Liabilities	$659.0K	$695.0K	$0.00
Total Liabilities	$2.020M	$3.590M	$1.033M
YoY Change	200.15%	247.53%	-66.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$380.5M	-$376.2M
YoY Change	5.38%
Common Stock	$48.00K	$48.00K
YoY Change	-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.47M	$42.70M	$62.05M
YoY Change
Total Liabilities & Shareholders Equity	$40.49M	$46.29M	$63.08M
YoY Change	-29.83%	-26.62%	-1.69%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$4.389M	-$6.385M	-$3.826M
YoY Change	-24.92%	66.88%	15.73%
Depreciation, Depletion And Amortization	$170.0K	$28.00K	$176.0K
YoY Change	-12.37%	-84.09%	31.34%
Cash From Operating Activities	-$6.069M	-$4.968M	-$3.457M
YoY Change	5.64%	43.71%	15.66%
INVESTING ACTIVITIES
Capital Expenditures	$175.0K	-$20.00K	-$87.00K
YoY Change	-212.9%	-77.01%	2075.0%
Acquisitions
YoY Change
Other Investing Activities	$3.538M	$270.0K	-$279.0K
YoY Change	581.7%	-196.77%	-97.09%
Cash From Investing Activities	$3.363M	$250.0K	-$366.0K
YoY Change	823.9%	-168.31%	-96.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	25.00K	30.00K
YoY Change	-100.0%	-16.67%	-99.83%
NET CHANGE
Cash From Operating Activities	-6.069M	-4.968M	-3.457M
Cash From Investing Activities	3.363M	250.0K	-366.0K
Cash From Financing Activities	0.000	25.00K	30.00K
Net Change In Cash	-2.706M	-4.693M	-3.793M
YoY Change	-48.52%	23.73%	-182.67%
FREE CASH FLOW
Cash From Operating Activities	-$6.069M	-$4.968M	-$3.457M
Capital Expenditures	$175.0K	-$20.00K	-$87.00K
Free Cash Flow	-$6.244M	-$4.948M	-$3.370M
YoY Change	11.7%	46.82%	12.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000946644
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2022Q3	AIM	Redeemable Warrants RedeemableWarrants		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://aimimmuno.com/20220930#ClinicalTreatmentProgramsUSMember
CY2021Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://aimimmuno.com/20220930#ClinicalTreatmentProgramsUSMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://aimimmuno.com/20220930#ClinicalTreatmentProgramsUSMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://aimimmuno.com/20220930#ClinicalTreatmentProgramsUSMember
CY2022Q3	us-gaap	Manufacturing Costs ManufacturingCosts		usd
	us-gaap	Manufacturing Costs ManufacturingCosts		usd
CY2021Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022Q3	us-gaap	Interest Expense InterestExpense		usd
CY2021Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q3	AIM	Reclassification Adjustment For Realized Investment Lost ReclassificationAdjustmentForRealizedInvestmentLost		usd
	AIM	Reclassification Adjustment For Realized Investment Lost ReclassificationAdjustmentForRealizedInvestmentLost		usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q3	AIM	Cashless Warrant Value Conversion CashlessWarrantValueConversion		usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	AIM	Extinguishment Of Financing Obligation And Note Payables ExtinguishmentOfFinancingObligationAndNotePayables		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	AIM	Payment Of Financing Obligation PaymentOfFinancingObligation		usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
	AIM	Operating Leaseright Of Use Assets OperatingLeaserightOfUseAssets		usd
CY2021	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss		usd
CY2022Q3	AIM	Accrued Clinical Trial Expenses Current AccruedClinicalTrialExpensesCurrent		usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity File Number EntityFileNumber	001-27072
	dei	Entity Registrant Name EntityRegistrantName	AIM IMMUNOTECH INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0845822
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2117 SW Highway 484
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ocala
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34473
	dei	City Area Code CityAreaCode	(352)
	dei	Local Phone Number LocalPhoneNumber	448-7797
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	AIM
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48082275	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29759000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32093000	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	6986000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16175000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1641000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	805000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	304000	usd
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	3600000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	41150000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	50213000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4047000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	866000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	149000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2013000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1974000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2138000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1316000	usd
CY2022Q3	us-gaap	Assets Assets	46285000	usd
CY2021Q4	us-gaap	Assets Assets	57699000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	957000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	198000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1767000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	438000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	171000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2895000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	673000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	695000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	112000	usd
CY2021Q4	AIM	Redeemable Warrants RedeemableWarrants	35000	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	713000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	715000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48082275	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48082275	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47994672	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47994672	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	48000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	48000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	418091000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	417217000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-376157000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-361101000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	42695000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	56879000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46285000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57699000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	85000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	85000	usd
CY2021Q3	us-gaap	Manufacturing Costs ManufacturingCosts	157000	usd
	us-gaap	Manufacturing Costs ManufacturingCosts	674000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1372000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2006000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4883000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4749000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5170000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1799000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9569000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6055000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	6542000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	3962000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	14452000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	11478000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6521000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3929000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14367000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11393000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2206000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4047000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	275000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6385000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	42695000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61294000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12887000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	526000	usd
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3742000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	70965000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	480000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5913000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	65532000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	314000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3829000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3829000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	62047000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15056000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13281000	usd
	us-gaap	Depreciation Depreciation	29000	usd
	us-gaap	Depreciation Depreciation	484000	usd
	AIM	Redeemable Warrants Valuation Adjustment RedeemableWarrantsValuationAdjustment	-35000	usd
	AIM	Redeemable Warrants Valuation Adjustment RedeemableWarrantsValuationAdjustment	-22000	usd
	AIM	Extinguishment Of Financing Obligation And Note Payables ExtinguishmentOfFinancingObligationAndNotePayables	2701000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	97000	usd
	AIM	Increase Decreasein Rightof Use Assets IncreaseDecreaseinRightofUseAssets	-717000	usd
	AIM	Increase Decreasein Rightof Use Assets IncreaseDecreaseinRightofUseAssets	35000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	216000	usd
	AIM	Gain From Sale Of Income Tax Operating Losses GainFromSaleOfIncomeTaxOperatingLosses	-749000	usd
	AIM	Gain From Sale Of Income Tax Operating Losses GainFromSaleOfIncomeTaxOperatingLosses	-542000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	792000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1320000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1768000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-126000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	47000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1641000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1090000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	500000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-64000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	717000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-35000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	73000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	758000	usd
	us-gaap	Depreciation Depreciation	29000	usd
	us-gaap	Depreciation Depreciation	484000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1329000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-80000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10039000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8220000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9082000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	849000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1661000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1611000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	300000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	245000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	96000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	444000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7625000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-995000	usd
	AIM	Payment Of Financing Obligation PaymentOfFinancingObligation	4732000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	122000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	80000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	12917000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	80000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8063000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2334000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1152000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32093000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38501000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29759000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37349000	usd
	AIM	Operating Leaseright Of Use Assets OperatingLeaserightOfUseAssets	717000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1170000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-329000	usd
	AIM	Conversion Of Series B Preferred ConversionOfSeriesBPreferred	2000	usd
	AIM	Conversion Of Series B Preferred ConversionOfSeriesBPreferred	7000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	792000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1320000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	179000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1800000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1535000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	169000	usd
CY2021Q4	AIM	Accrued Clinical Trial Expenses Current AccruedClinicalTrialExpensesCurrent	61000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2353000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6253000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2235000	usd
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	279000	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	6986000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16175000	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-365000	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	6986000	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	6986000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-1769000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-598000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1171000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	16175000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16175000	usd
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-88000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-88000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	199000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	207000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1767000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	438000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1769000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	172000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	296000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	100000	usd
	us-gaap	Interest Expense InterestExpense	67000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2701000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	216000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-51000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-35000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-22000	usd
CY2022Q3	AIM	Gain From Sale Of Income Tax Operating Loss GainFromSaleOfIncomeTaxOperatingLoss	-328000	usd
CY2021Q3	AIM	Gain From Sale Of Income Tax Operating Loss GainFromSaleOfIncomeTaxOperatingLoss	-72000	usd
	AIM	Gain From Sale Of Income Tax Operating Loss GainFromSaleOfIncomeTaxOperatingLoss	-749000	usd
	AIM	Gain From Sale Of Income Tax Operating Loss GainFromSaleOfIncomeTaxOperatingLoss	-542000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6385000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3826000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15056000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13281000	usd
CY2021Q3	AIM	Reclassification Adjustment For Realized Investment Lost ReclassificationAdjustmentForRealizedInvestmentLost	101000	usd
	AIM	Reclassification Adjustment For Realized Investment Lost ReclassificationAdjustmentForRealizedInvestmentLost	126000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-104000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-329000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6385000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3829000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15056000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13484000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	48079210	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	47846074	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	48036559	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	47156158	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	56879000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	242000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3820000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	53301000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	55000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	275000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4851000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	48780000	usd
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1498000	usd
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	592000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	116000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1974000	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	96000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2013000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	23000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	154000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	178000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	199000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	235000	usd
CY2022Q3	AIM	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	1224000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2013000	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q3	AIM	Common Stock Shares With Limitations And Restrictions On Usage CommonStockSharesWithLimitationsAndRestrictionsOnUsage	8000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48082275	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47994672	shares
	AIM	Percentage Of Probability PercentageOfProbability	0.050	pure
	AIM	Floor Rate Used As Proxy For Future Volatility Percentage FloorRateUsedAsProxyForFutureVolatilityPercentage	1	pure
CY2022Q3	us-gaap	Derivative Assets DerivativeAssets	6986000	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	16175000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	35000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Fair Value Disclosure PropertyPlantAndEquipmentFairValueDisclosure	3900000	usd
CY2021	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	-1800000	usd
CY2021	us-gaap	Property Plant And Equipment Collections Not Capitalized Deaccessed Fair Value PropertyPlantAndEquipmentCollectionsNotCapitalizedDeaccessedFairValue	3900000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1800000	usd
CY2022Q3	AIM	Deposit Received DepositReceived	300000	usd
CY2018Q1	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	4080000	usd
CY2018Q1	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	lease the property back for ten years at $408,000 per year for two years through March 31, 2020. The lease payments would increase 2.5% per year for the next three years through March 31, 2023, and the lease payments would increase 3% for the remaining five years through March 31, 2028
CY2018Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2018Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	73314	shares
CY2018Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2018Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	17.05
CY2018Q1	AIM	Warrant Closing Price Percentages WarrantClosingPricePercentages	1.25	pure
CY2021Q2	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	4732637	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M1D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M19D
	AIM	Percentage Of Incremental Borrowing Rate PercentageOfIncrementalBorrowingRate	0.10	pure
CY2021	AIM	Percentage Of Incremental Borrowing Rate PercentageOfIncrementalBorrowingRate	0.10	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	46000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	187000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	183000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	180000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	185000	usd
CY2022Q3	AIM	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	171000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	86000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	866000	usd
CY2022Q3	AIM	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	866000	usd
CY2021Q4	AIM	Operating Leases Right Of Use Asset OperatingLeasesRightOfUseAsset	149000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	866000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	149000	usd
	us-gaap	Payments For Rent PaymentsForRent	75000	usd
	us-gaap	Payments For Rent PaymentsForRent	39000	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	8000	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	8000	usd

Files In Submission

Name	View Source	Status
0001493152-22-032118-index-headers.html	Edgar Link	pending
0001493152-22-032118-index.html	Edgar Link	pending
0001493152-22-032118.txt	Edgar Link	pending
0001493152-22-032118-xbrl.zip	Edgar Link	pending
aim-20220930.xsd	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
aim-20220930_cal.xml	Edgar Link	unprocessable
aim-20220930_def.xml	Edgar Link	unprocessable
ex10-4_001.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aim-20220930_lab.xml	Edgar Link	unprocessable
aim-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIM
AIM ImmunoTech Inc. Stock $aim

2022 Q4 Form 10-Q Financial Statement

#000149315222032118 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIM AIM ImmunoTech Inc. Stock $aim

2022 Q4 Form 10-Q Financial Statement

#000149315222032118 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIM
AIM ImmunoTech Inc. Stock $aim